These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 16084324)

  • 1. The prognosis of mixed connective tissue disease.
    Lundberg IE
    Rheum Dis Clin North Am; 2005 Aug; 31(3):535-47, vii-viii. PubMed ID: 16084324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle involvement in mixed connective tissue disease.
    Hall S; Hanrahan P
    Rheum Dis Clin North Am; 2005 Aug; 31(3):509-17, vii. PubMed ID: 16084322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raynaud's phenomenon in mixed connective tissue disease.
    Grader-Beck T; Wigley FM
    Rheum Dis Clin North Am; 2005 Aug; 31(3):465-81, vi. PubMed ID: 16084319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does mixed connective tissue disease exist? Yes.
    Aringer M; Steiner G; Smolen JS
    Rheum Dis Clin North Am; 2005 Aug; 31(3):411-20, v. PubMed ID: 16084315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies in the pathogenesis of mixed connective tissue disease.
    Greidinger EL; Hoffman RW
    Rheum Dis Clin North Am; 2005 Aug; 31(3):437-50, vi. PubMed ID: 16084317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings.
    Burdt MA; Hoffman RW; Deutscher SL; Wang GS; Johnson JC; Sharp GC
    Arthritis Rheum; 1999 May; 42(5):899-909. PubMed ID: 10323445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mixed connective tissue disease--etiology, pathogenesis, clinical significance, treatment].
    Zdrojewicz Z; Budzyń-Kozioł E; Puławska J
    Postepy Hig Med Dosw; 1999; 53(5):751-66. PubMed ID: 10645148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of mixed connective tissue disease.
    Kim P; Grossman JM
    Rheum Dis Clin North Am; 2005 Aug; 31(3):549-65, viii. PubMed ID: 16084325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and immunoserological characteristics of mixed connective tissue disease associated with pulmonary arterial hypertension.
    Vegh J; Szodoray P; Kappelmayer J; Csipo I; Udvardy M; Lakos G; Aleksza M; Soltesz P; Szilágyi A; Zeher M; Szegedi G; Bodolay E
    Scand J Immunol; 2006 Jul; 64(1):69-76. PubMed ID: 16784493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed connective tissue disease: still crazy after all these years.
    Swanton J; Isenberg D
    Rheum Dis Clin North Am; 2005 Aug; 31(3):421-36, v. PubMed ID: 16084316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse.
    Amigues JM; Cantagrel A; Abbal M; Mazieres B
    J Rheumatol; 1996 Dec; 23(12):2055-62. PubMed ID: 8970041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary manifestations of scleroderma and mixed connective tissue disease.
    Hant FN; Herpel LB; Silver RM
    Clin Chest Med; 2010 Sep; 31(3):433-49. PubMed ID: 20692538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Other manifestations of mixed connective tissue disease.
    Pope JE
    Rheum Dis Clin North Am; 2005 Aug; 31(3):519-33, vii. PubMed ID: 16084323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological analysis of pulmonary hypertension in connective tissue diseases.
    Nishimaki T; Aotsuka S; Kondo H; Yamamoto K; Takasaki Y; Sumiya M; Yokohari R
    J Rheumatol; 1999 Nov; 26(11):2357-62. PubMed ID: 10555891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A possible role of anti-endothelial cell antibody in the sera of MCTD patients on pulmonary vascular damage relating to pulmonary hypertension].
    Sasaki N; Kurose A; Inoue H; Sawai T
    Ryumachi; 2002 Dec; 42(6):885-94. PubMed ID: 12632608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensorineural hearing loss in patients with mixed connective tissue disease: immunological markers and cytokine levels.
    Hajas A; Szodoray P; Barath S; Sipka S; Rezes S; Zeher M; Sziklai I; Szegedi G; Bodolay E
    J Rheumatol; 2009 Sep; 36(9):1930-6. PubMed ID: 19684145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed connective tissue disease.
    Gunnarsson R; Hetlevik SO; Lilleby V; Molberg Ø
    Best Pract Res Clin Rheumatol; 2016 Feb; 30(1):95-111. PubMed ID: 27421219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary hypertension not a major feature of early mixed connective tissue disease: a prospective clinicoserological study.
    Haroon N; Nisha RS; Chandran V; Bharadwaj A
    J Postgrad Med; 2005; 51(2):104-7, discussion 107-8. PubMed ID: 16006700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overlapping syndromes, undifferentiated connective tissue disease, and other fibrosing conditions.
    Kallenberg CG
    Curr Opin Rheumatol; 1992 Dec; 4(6):837-42. PubMed ID: 1457278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal primary pulmonary hypertension in mixed connective tissue disease.
    Eulderink F; Cats A
    Z Rheumatol; 1981; 40(1):25-9. PubMed ID: 7223079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.